Maintenance of platelet inhibition during antiplatelet therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10022391
SERIAL NO

15136979

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for reducing or maintaining platelet inhibition in a patient by administering cangrelor prior to an invasive procedure is described. The method of this invention can be used for patients in need of antiplatelet therapy or at risk of thrombosis. The method can further be used in patients who were previously treated with long-acting platelet inhibitors without increasing the risk of excessive bleeding.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHIESI FARMACEUTICI S P AVIA PALERMO 26/A PARMA 43122

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bell, Dawn Morristown, US 12 347
Prats, Jayne Carlisle, US 16 368
Ruderman, Chen Lisa Rye, US 9 301
Skerjanec, Simona Basel, CH 22 412
Todd, Meredith Hoboken, US 10 316

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 17, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 17, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00